Literature DB >> 23613646

Expression trend of selected ribosomal protein genes in nasopharyngeal carcinoma.

Xiang-Ru Ma1, Edmund Ui-Hang Sim, Teck-Yee Ling, Thung-Sing Tiong, Selva Kumar Subramaniam, Alan Soo-Beng Khoo.   

Abstract

BACKGROUND: Ribosomal proteins are traditionally associated with protein biosynthesis until recent studies that implicated their extraribosomal functions in human diseases and cancers. Our previous studies using GeneFishing™ DEG method and microarray revealed underexpression of three ribosomal protein genes, RPS26, RPS27, and RPL32 in cancer of the nasopharynx. Herein, we investigated the expression pattern and nucleotide sequence integrity of these genes in nasopharyngeal carcinoma to further delineate their involvement in tumourigenesis. The relationship of expression level with clinicopathologic factors was also statistically studied.
METHODS: Quantitative Polymerase Chain Reaction was performed on nasopharyngeal carcinoma and their paired normal tissues. Expression and sequence of these three genes were analysed.
RESULTS: All three ribosomal protein genes showed no significant difference in transcript expressions and no association could be established with clinicopathologic factors studied. No nucleotide aberrancy was detected in the coding regions of these genes.
CONCLUSION: There is no early evidence to substantiate possible involvement of RPS26, RPS27, and RPL32 genes in NPC tumourigenesis.

Entities:  

Keywords:  NPC; RP; RPL32; RPS26; RPS27; transcript expression

Year:  2012        PMID: 23613646      PMCID: PMC3629677     

Source DB:  PubMed          Journal:  Malays J Med Sci        ISSN: 1394-195X


  37 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  In vitro and in vivo evidence of metallopanstimulin-1 in gastric cancer progression and tumorigenicity.

Authors:  Yun-Wei Wang; Ying Qu; Jian-Fang Li; Xue-Hua Chen; Bing-Ya Liu; Qin-Long Gu; Zheng-Gang Zhu
Journal:  Clin Cancer Res       Date:  2006-08-15       Impact factor: 12.531

3.  Expression of metallopanstimulin and oncogenesis in human prostatic carcinoma.

Authors:  J A Fernandez-Pol; J W Fletcher; P D Hamilton; D J Klos
Journal:  Anticancer Res       Date:  1997 May-Jun       Impact factor: 2.480

4.  Defective ribosomal protein gene expression alters transcription, translation, apoptosis, and oncogenic pathways in Diamond-Blackfan anemia.

Authors:  Hanna T Gazda; Alvin T Kho; Despina Sanoudou; Jan M Zaucha; Isaac S Kohane; Colin A Sieff; Alan H Beggs
Journal:  Stem Cells       Date:  2006-06-01       Impact factor: 6.277

5.  Identification of metallopanstimulin-1 as a member of a tumor associated antigen in patients with breast cancer.

Authors:  Yoshiaki Atsuta; Naoko Aoki; Keisuke Sato; Kensuke Oikawa; Hitoshi Nochi; Naoyuki Miyokawa; Satoshi Hirata; Shoji Kimura; Tadahiro Sasajima; Makoto Katagiri
Journal:  Cancer Lett       Date:  2002-08-08       Impact factor: 8.679

6.  The ribosomal protein L32-2 (RPL32-2) of S. pombe exhibits a novel extraribosomal function by acting as a potential transcriptional regulator.

Authors:  Jing Wang; Wang Jing; Sheng Yuan; Yuan Sheng; Shibo Jiang; Shibo Jang
Journal:  FEBS Lett       Date:  2006-02-24       Impact factor: 4.124

7.  Prediction of prognosis of estrogen receptor-positive breast cancer with combination of selected estrogen-regulated genes.

Authors:  Nobuyuki Yoshida; Yoko Omoto; Akio Inoue; Hidetaka Eguchi; Yasuhito Kobayashi; Masafumi Kurosumi; Shigehira Saji; Kimito Suemasu; Tomoki Okazaki; Kei Nakachi; Toshiro Fujita; Shin-ichi Hayashi
Journal:  Cancer Sci       Date:  2004-06       Impact factor: 6.716

8.  Expression profile of differentially-regulated genes during progression of androgen-independent growth in human prostate cancer cells.

Authors:  Dev Karan; David L Kelly; Angie Rizzino; Ming-Fong Lin; Surinder K Batra
Journal:  Carcinogenesis       Date:  2002-06       Impact factor: 4.944

9.  Loss of p53 synthesis in zebrafish tumors with ribosomal protein gene mutations.

Authors:  Alyson W MacInnes; Adam Amsterdam; Charles A Whittaker; Nancy Hopkins; Jacqueline A Lees
Journal:  Proc Natl Acad Sci U S A       Date:  2008-07-18       Impact factor: 11.205

10.  Metallopanstimulin as a marker for head and neck cancer.

Authors:  Brendan C Stack; Christopher S Hollenbeak; Christopher M Lee; Frank R Dunphy; Val J Lowe; Paul D Hamilton
Journal:  World J Surg Oncol       Date:  2004-12-14       Impact factor: 2.754

View more
  5 in total

Review 1.  The roles of ribosomal proteins in nasopharyngeal cancer: culprits, sentinels or both.

Authors:  Edmund Ui-Hang Sim; Choon-Weng Lee; Kumaran Narayanan
Journal:  Biomark Res       Date:  2021-06-30

2.  Human Ribosomal Proteins RPeL27, RPeL43, and RPeL41 Are Upregulated in Nasopharyngeal Carcinoma Cell Lines.

Authors:  Edmund Ui-Hang Sim; Stella Li-Li Chan; Kher-Lee Ng; Choon-Weng Lee; Kumaran Narayanan
Journal:  Dis Markers       Date:  2016-11-28       Impact factor: 3.434

3.  The uS8, uS4, eS31, and uL14 Ribosomal Protein Genes Are Dysregulated in Nasopharyngeal Carcinoma Cell Lines.

Authors:  Edmund Ui-Hang Sim; Kher-Lee Ng; Choon-Weng Lee; Kumaran Narayanan
Journal:  Biomed Res Int       Date:  2017-07-16       Impact factor: 3.411

4.  Regulation of COL1A2, AKT3 genes, and related signaling pathway in the pathology of congenital talipes equinovarus.

Authors:  Ningqing Wang; Jiangchao Zhang; Haixiang Lv; Zhenjiang Liu
Journal:  Front Pediatr       Date:  2022-07-22       Impact factor: 3.569

5.  Proteomic Characterization of Proliferation Inhibition of Well-Differentiated Laryngeal Squamous Cell Carcinoma Cells Under Below-Background Radiation in a Deep Underground Environment.

Authors:  Jifeng Liu; Tengfei Ma; Mingzhong Gao; Yilin Liu; Jun Liu; Shichao Wang; Yike Xie; Qiao Wen; Ling Wang; Juan Cheng; Shixi Liu; Jian Zou; Jiang Wu; Weimin Li; Heping Xie
Journal:  Front Public Health       Date:  2020-10-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.